date:Feb 24, 2014
Groupe Danone said its yogurt business, coming off a successful 2013, soon may benefit from a U.S. Food and Drug Administration determination.
We just got the authorization from the F.D.A. with three health claim links to Activia, to the digestive system, which will help us again re-launch, without the Greek vision, the core business of Activia, said Franck Riboud, chairman and chief executive officer of Groupe Danone, in a Feb. 20 earnings call.
The company is looking at how it may advertise